Frequency of cytochrome P450 2C9 mutant alleles in a Korean population
- 1 March 2001
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 51 (3) , 277-280
- https://doi.org/10.1046/j.1365-2125.2001.00340.x
Abstract
Aims To determine the frequencies of CYP2C9 variants in the Korean population and compare them with the frequencies in other ethnic populations.Methods Genotyping of CYP2C9*2 and CYP2C9*3 allelic variants was carried out in 574 Korean subjects by PCR and restriction fragment length pattern analysis.Results Thirteen of 574 subjects (2.3%) were heterozygous for CYP2C9*3 (Ile359Leu), but no subjects with a CYP2C9*2 allele or homozygous for CYP2C9*3 were identified. The allele frequency of CYP2C9*3 in Korean subjects (0.0113, 95% CI 0.0066–0.0193) was similar to that of other East Asian populations, but was considerably lower than that of Caucasian populations.Conclusions CYP2C9*3 seems to be an allelic variant related to the functional polymorphism of CYP2C9, but this variant is rarely seen among Koreans compared with Caucasians. Routine genotyping of the CYP2C9*2 allele is considered to be unnecessary in Korean and East Asians, because this allele appears to be extremely rare or absent in these populations.Keywords
This publication has 13 references indexed in Scilit:
- Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish PopulationBiochemical and Biophysical Research Communications, 1999
- Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypesPharmacogenetics, 1998
- Comparative Studies on the Catalytic Roles of Cytochrome P450 2C9 and Its Cys- and Leu-Variants in the Oxidation of Warfarin, Flurbiprofen, and Diclofenac by Human Liver MicrosomesBiochemical Pharmacology, 1998
- Cytochrome P4502C9: an enzyme of major importance in human drug metabolismBritish Journal of Clinical Pharmacology, 1998
- Genetic analysis of CYP2C9 polymorphism in a Japanese populationPharmacogenetics, 1997
- Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, CaliforniaPharmacogenetics, 1996
- The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphismPharmacogenetics, 1996
- Detection of CYP2C9 polymorphism based on the polymerase chain reaction in ChinesePharmacogenetics, 1995
- Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9Pharmacogenetics, 1994
- A general method for isolation of high molecular weight DNA from eukaryotesNucleic Acids Research, 1976